Legg-Calvé-Perthes syndrome epidemiology and demographics

Legg-Calvé-Perthes syndrome Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Legg-Calvé-Perthes syndrome from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Physical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Legg-Calvé-Perthes syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Legg-Calvé-Perthes syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Legg-Calvé-Perthes syndrome epidemiology and demographics
CDC on Legg-Calvé-Perthes syndrome epidemiology and demographics
Legg-Calvé-Perthes syndrome epidemiology and demographics in the news
Blogs on Legg-Calvé-Perthes syndrome epidemiology and demographics
Directions to Hospitals Treating Legg-Calvé-Perthes syndrome
Risk calculators and risk factors for Legg-Calvé-Perthes syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Prevelance

Perthes is a relatively unusual condition, with only 4 per 100,000 children being affected.

Age

It is most commonly seen in persons aged 3-12 years, with a median of 6 years of age.

Gender

Males are affected 4-5 times more often than females, suggesting a partial sex-linked genetic inheritance of the the syndrome. 1 in 100 male children of adults with Legg-Calvé-Perthes syndrome also exhibit the syndrome.

Race

Caucasians are affected more frequently than other races.